Aastrom Biosciences Spokesperson Comments on Monday's Option Activity

Aastrom Biosciences

call volume was at 4,905% of average on Monday. There was no specific news to account for the option activity. The August 2.50 call was particularly active with volume at 5,030 contracts, compared with open interest of 961. An Aastrom spokesperson commented to Benzinga on the activity: "As you know, it is very difficult for us to fully understand and to comment on option activity in our stock. In terms of upcoming news, we have disclosed publicly that we will be releasing final data from our DCM Catheter program during the 2nd quarter, however we have not yet specified the date or venue publicly. A press release will be issued as soon as we can disclose the details. "We are not suggesting that this is or is not impacting the option activity, we are simply informing you of upcoming news in response to your question." Aastrom Biosciences closed at $2.64 on Monday.